Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis
2014 StandoutNobel
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Infective Endocarditis
2005 Standout
Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial
2009 Standout
Antimicrobial therapy for patients with severe sepsis and septic shock: An evidence-based review
2004
Clinical impact of antibiotic-resistant Gram-positive pathogens
2009
The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium
1999
The Incidence of and Clinical Variables Associated With Vancomycin-Resistant Enterococcal Colonization in Mechanically Ventilated Patients
1999
Vancomycin‐Resistant and Vancomycin‐Susceptible Enterococcal Bacteremia: Comparison of Clinical Features and Outcomes
1998
Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome
1995
The Impact of Culture Isolation ofAspergillusSpecies: A Hospital‐Based Survey of Aspergillosis
2001
Infection Control and Cost Control in the Era of Managed Care
2002
A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment
2006 Standout
Critical illness myopathy and neuropathy
2005
Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Infection and Impact of Resistance on Outcomes
2001
Fungal infections in the recipients of solid organ transplantation
2003
Weaning from mechanical ventilation
2007 Standout
Cost-Effectiveness of Perirectal Surveillance Cultures for Controlling Vancomycin-ResistantEnterococcus
2002
Vancomycin-Resistant Enterococci Outside the Health-Care Setting: Prevalence, Sources, and Public Health Implications
1997
Successful Liver Transplantation Following Medical Management of Portopulmonary Hypertension: A Single-Center Series
2006
Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme
1999
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Resistance Patterns Among Nosocomial Pathogens
2001
Renal Failure in Cirrhosis
2009
Molecular mechanisms that confer antibacterial drug resistance
2000 Nature
Antibiotic resistance of bacteria in biofilms
2001 Standout
Infection Control — A Problem for Patient Safety
2003 Standout
A Prospective Study to Determine Whether Cover Gowns in Addition to Gloves Decrease Nosocomial Transmission of Vancomycin-Resistant Enterococci in an Intensive Care Unit
2002
The Perioperative Management of Portopulmonary Hypertension with Nitric Oxide and Epoprostenol
1999
VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM MENINGITIS SUCCESSFULLY TREATED WITH CHLORAMPHENICOL
1999
Severe Sepsis and Septic Shock
2013 Standout
Causes of neuromuscular weakness in the intensive care unit: A study of ninety-two patients
1998
Influence of Airway Management on Ventilator-Associated Pneumonia
1998
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review
2012 Standout
Primary Cytomegalovirus Infection in Liver Transplant Recipients: Comparison of Infections Transmitted Via Donor Organs and Via Transfusions
1996
PORTOPULMONARY HYPERTENSION AND THE LIVER TRANSPLANT CANDIDATE
1999
Clinical Outcomes for Patients with Bacteremia Caused by Vancomycin‐Resistant Enterococcus in a Level 1 Trauma Center
2002
Acute kidney injury
2019 Standout
Hepatopulmonary syndrome: Favorable outcomes in the MELD exception era
2012
Pulmonary dysfunction in chronic liver disease
2000
Low-Tidal-Volume Ventilation in the Acute Respiratory Distress Syndrome
2007
The evaluation of renal function and disease in patients with cirrhosis
2010
INCIDENCE AND OUTCOME OF INFECTION BY VANCOMYCIN-RESISTANTENTEROCOCCUS FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION
1998
Enterococcus faecium Bacteremia
1998
Neuromuscular dysfunction acquired in critical illness: a systematic review
2007
Hydrocortisone Therapy for Patients with Septic Shock
2008 Standout
Reasons for Noncompliance With Infection Control Guidelines
2000
Vancomycin-Resistant Enterococci
2003
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
2011 Standout
Hepatorenal Disorders
2015
Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii
2007
The Role of Chloramphenicol in the Treatment of Bloodstream Infection Due to Vancomycin‐ResistantEnterococcus
1998
Acetaminophen‐induced acute liver failure
2005 Standout
Paresis Acquired in the Intensive Care Unit<SUBTITLE>A Prospective Multicenter Study</SUBTITLE>
2002 Standout
Enterococcal Bacteremia: Risk Factors for Vancomycin Resistance and Predictors of Mortality
1999
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Control of Endemic Vancomycin-Resistant Enterococcus among Inpatients at a University Hospital
2003
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Resistance to Glycopeptides in Enterococci
1997
Kidney biomarkers in cirrhosis
2016
A Potential Decline in Life Expectancy in the United States in the 21st Century
2005 Standout
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia☆
2000
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS
2008
Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and Canada
1998
Efficacy and safety of Amphotericin B Lipid Complex Injection (ABLC) in solid‐organ transplant recipients with invasive fungal infections
2000
Vancomycin‐Resistant Enterococcus faecium in a Long‐Term Care Facility
1998
Impact of the More-Potent Antibiotics Quinupristin-Dalfopristin and Linezolid on Outcome Measure of Patients with Vancomycin-Resistant Enterococcus Bacteremia
2007
A Hospital Epidemic of Vancomycin-Resistant Enterococcus Risk Factors and Control
2001
Infection in Solid-Organ Transplant Recipients
2007 Standout
Paresis following mechanical ventilation
2004
Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management
2003
Herpes Zoster
2013 Standout
Quantifying Human Health Risks from Virginiamycin Used in Chickens
2004
Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury
2013
Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis
2003
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
2007 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Health and Economic Outcomes of Vancomycin-Resistant Enterococci
2002
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
2004 Standout
Management of multidrug-resistant organisms in health care settings, 2006
2007
Treatment of Vancomycin‐ResistantEnterococcus faeciumInfections with Quinupristin/Dalfopristin
2001
Impact of Vancomycin Resistance on Mortality among Patients with Neutropenia and Enterococcal Bloodstream Infection
2005
Critical Illness Neuromuscular Syndromes
2007
Clinical implications of antimicrobial resistance for therapy
2008
Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome
2010 Standout
The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study
2009
Clinical Failures of Linezolid and Implications for the Clinical Microbiology Laboratory
2002
Gut Microbiota in Health and Disease
2010 Standout
Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy
1995
Reference Group Choice and Antibiotic Resistance Outcomes
2004
Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study
2001
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
AspergillusInfections in Transplant Recipients
2005
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
1997 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]‐Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE
2016 StandoutNobel
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria
2003 Standout
Food Animals and Antimicrobials: Impacts on Human Health
2011 Standout
Quinupristin/dalfopristin: therapeutic potential for vancomycin-resistant enterococcal infections
1999
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients
1998 Standout
The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs
2005 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Comparison of Mortality Associated with Vancomycin-Resistant and Vancomycin-Susceptible Enterococcal Bloodstream Infections: A Meta-analysis
2005
Uridine-Based Inhibitors as New Leads for Antibiotics Targeting Escherichia coli LpxC
2009 StandoutNobel
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Works of Dion Kramer being referenced
Differences in Outcomes for Patients with Bacteremia Due to Vancomycin-Resistant Enterococcus faecium or Vancomycin-Susceptible E. faecium
1996
Kidney Allocation to Liver Transplant Candidates with Renal Failure of Undetermined Etiology: Role of Percutaneous Renal Biopsy
2008
Effect of quinupristin/dalfopristin on the outcome of vancomycin- resistant Enterococcus faecium bacteraemia: comparison with a control cohort
1997
The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation
1993
Reversibility of the hepatopulmonary syndrome by orthotopic liver transplantation.
1993
Hemodynamic effects of inhaled nitric oxide in four patients with severe liver disease and pulmonary hypertension
1997
Acute liver failure: Clinical features, outcomeanalysis, and applicability of prognostic criteria
2000
Effects of continuous lateral rotation therapy on pulmonary complications in liver transplant patients
1995
Acute myopathy after liver transplantation
1998
INVASIVE ASPERGILLOSIS IN LIVER TRANSPLANT RECIPIENTS: COMPARISON OF OUTCOME WITH AMPHOTERICIN B LIPID-COMPLEX AND CONVENTIONAL AMPHOTERICIN B THERAPY
1999